Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control.
about
Advances in Understanding and Managing Chronic UrticariaChronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapyProfile of omalizumab in the treatment of chronic spontaneous urticariaInsights and advances in chronic urticaria: a Canadian perspective.Validity, reliability and interpretability of the Thai version of the urticaria control test (UCT)Chronic spontaneous urticaria - a management pathway for patients with chronic spontaneous urticaria.An individualized diagnostic approach based on guidelines for chronic urticaria (CU).Development and validation of the mastocytosis quality of life questionnaire: MC-QoL.Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria.Chronic urticaria in the real-life clinical practice setting in Sweden, Norway and Denmark: baseline results from the non-interventional multicentre AWARE study.H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.Omalizumab for treating chronic spontaneous urticaria: an expert review on efficacy and safety.Patient-reported outcomes (PROs) in chronic urticaria.Management of chronic spontaneous urticaria (CSU): a treat to target approach using a patient reported outcome.Disease Severity, Activity, Impact, and Control and How to Assess Them in Patients with Hereditary Angioedema.Disease-specific impairment of the quality of life in adult patients with chronic spontaneous urticaria.Chronic urticaria: tools to aid the diagnosis and assessment of disease status in daily practice.Functional and phenotypic analysis of basophils allows determining distinct subtypes in patients with chronic urticaria.Chronic urticaria in most patients is poorly controlled. Results of the development, validation, and real life application of the arabic urticaria control test.Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria.Omalizumab for Management of Refractory Urticaria: Experience of a Tertiary Care Centre in Eastern India.Antihistamine updosing in chronic urticaria - is there enough evidence?Definition, aims, and implementation of GA(2) LEN Urticaria Centers of Reference and Excellence.Omalizumab in Chronic Spontaneous Urticaria Refractory to Conventional Therapy: An Italian Retrospective Clinical Analysis with Suggestions for Long-Term Maintenance Strategies.Epidemiology of urticaria in Poland - nationally representative survey results.Chronic spontaneous urticaria - a management pathway for patients with chronic spontaneous urticariaOmalizumab for urticaria treatment in clinical practice: a case seriesDifferences in chronic spontaneous urticaria between Europe and Central/South America: results of the multi-center real world AWARE study
P2860
Q26767461-E282ADB7-A03C-4A99-9DBD-70FFFDEF8753Q26777088-A443720D-E5CA-457B-834A-F082D93DBC84Q26783158-882E3B1A-80EE-484B-BC41-A52F602C6502Q35108534-41A18B13-D213-486C-B398-EA669C93CEDEQ36796880-FF93ABD7-F8AA-4C7A-8BA1-9AB8A066F037Q38445637-35324062-ACD8-435A-BEA4-761CB7A0C658Q38520215-DC567361-4D85-491A-AB1A-28768E926B1CQ38707373-830C9A2A-F827-404A-A5B3-DC7D17CAD718Q38861332-FE3510AD-89EE-4E84-9023-652701CF5CA1Q38907508-4A92F19D-09C9-4167-9703-44626EB57F92Q38979639-122484FA-EF9B-402F-9DC6-E93876A34698Q38997626-7105D59E-AB14-455C-8A59-50C66363608DQ39343082-3FC8E76F-8FBA-4B1D-A124-EEC2837DACB6Q41507426-AC0D0182-46BF-445E-94EE-0439FE6A4F69Q47152048-690D14D2-FA92-48E8-9876-816921A64AFAQ47783261-E7DB9DA2-0454-4A6F-B390-AB7A6E0E317BQ48036221-CDBBC48B-6E98-4073-8412-8AE323BA89F4Q48323568-07CE6D00-3279-486B-A32E-E86901F03780Q49526540-3B02D6F3-9401-4EBE-9DB4-8450788DD24EQ50027346-FBB24918-7B89-46AD-9223-5D79FFBA87C8Q52661808-72818D64-3DF4-4A02-9376-361F19D31B4BQ52843804-E0DA141A-118A-44B3-AD8F-123AA1526ADAQ52854220-BF46A8F4-0E2A-4405-A9FB-689C479FF6A9Q55429844-6D4C91C4-BFE5-455F-B6DD-B7021B929D70Q55434497-DF40F4C5-7C63-463B-A05A-D0A1FF2AC255Q56637625-B889614F-4736-4BD7-9F24-D663267F33C1Q58727162-5A50AB40-4465-4884-90FE-9FD353DC2471Q59125367-4B016078-B6F0-4DC0-B5B8-83D5A3B4BC38
P2860
Development and validation of the Urticaria Control Test: a patient-reported outcome instrument for assessing urticaria control.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Development and validation of ...... r assessing urticaria control.
@en
Development and validation of ...... r assessing urticaria control.
@nl
type
label
Development and validation of ...... r assessing urticaria control.
@en
Development and validation of ...... r assessing urticaria control.
@nl
prefLabel
Development and validation of ...... r assessing urticaria control.
@en
Development and validation of ...... r assessing urticaria control.
@nl
P2093
P1476
Development and validation of ...... or assessing urticaria control
@en
P2093
Adriane Groffik
Karoline Krause
Karsten Weller
Marcus Maurer
Martin K Church
Peter Martus
Petra Staubach
Thomas B Casale
P304
1365-72, 1372.e1-6
P356
10.1016/J.JACI.2013.12.1076
P407
P577
2014-02-09T00:00:00Z